Emcure Pharmaceuticals share price
Emcure Pharmaceuticals Ltd. · NSE: EMCURE · Healthcare
Price, one year
Price range
- Open
- ₹1,776.00
- High
- ₹1,799.00
- Low
- ₹1,724.80
- Previous close
- ₹1,782.60
- Volume
- 1.4 L
- Market cap
- ₹33,586 Cr
Key statistics
Results to 30 Jun 2026 · Consolidated- P/E (TTM)
- 33.2
- Price to book
- 6.8
- Return on equity
- 20.4%
- EPS (TTM)
- ₹53.35
- Book value / share
- ₹260.93
- Debt to equity
- 0.24
- Revenue (TTM)
- ₹9,683 Cr
- Net profit (TTM)
- ₹1,011 Cr
- Sales growth, YoY
- +22.9%
- Profit growth, YoY
- +42.0%
- Operating margin
- 20.4%
- Net margin
- 10.4%
- Sales CAGR, 3 years
- —
- Profit CAGR, 3 years
- —
- Promoter holding
- 77.82%
- Promoter shares pledged
- 0.04%
Shareholding pattern
% of shares| Holder | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|
| Promoters | 77.87 | 77.83 | 77.82 |
| Foreign institutions | 3.35 | 4.88 | 4.94 |
| Domestic institutions | 6.10 | 8.46 | 8.49 |
| Mutual funds | 4.94 | 6.87 | 7.05 |
| Retail and others | 6.46 | 6.45 | 6.34 |
| Promoter pledge | 0.04 | 0.04 | 0.04 |
Results and announcements
Latest results (quarter to 30 Jun 2026) filed 6 Aug 2026. results: 3 Nov 2026.
Peers in Healthcare
All Healthcare stocks| Company | Price | Change |
|---|---|---|
| Sun Pharmaceutical IndustriesSUNPHARMA | ₹1,748.00 | −0.57% |
| Divi's LaboratoriesDIVISLAB | ₹8,950.00 | −2.31% |
| Torrent PharmaceuticalsTORNTPHARM | ₹4,524.40 | −1.97% |
| Zydus LifesciencesZYDUSLIFE | ₹1,129.40 | −0.49% |
| Apollo Hospitals EnterpriseAPOLLOHOSP | ₹7,730.00 | +1.65% |
| CiplaCIPLA | ₹1,338.00 | +0.53% |
| Laurus LabsLAURUSLABS | ₹1,970.00 | −1.62% |
| Dr. Reddy's LaboratoriesDRREDDY | ₹1,229.50 | −0.77% |
| Mankind PharmaMANKIND | ₹2,212.60 | −2.77% |
| Aurobindo PharmaAUROPHARMA | ₹1,571.70 | −2.43% |
Frequently asked questions
What is the share price of Emcure Pharmaceuticals today?
Emcure Pharmaceuticals (NSE: EMCURE) was at ₹1,770.40 on 23 Oct 2026, a change of −0.68% from the previous close.
What are the 52-week high and low of Emcure Pharmaceuticals?
Over the last 52 weeks Emcure Pharmaceuticals traded between ₹1,306.50 and ₹2,100.70 (daily highs and lows on NSE on 23 Oct 2026).
What is the market capitalisation of Emcure Pharmaceuticals?
About ₹33,586 Cr at the latest price, with a P/E of 33.2, a price-to-book of 6.8, a return on equity of 20.4%. Ratios use the company's latest reported results.
Who owns Emcure Pharmaceuticals shares?
According to the shareholding pattern filed with the exchange at the end of the quarter to 30 Sep 2026, promoters held 77.82%, foreign institutions 4.94%, domestic institutions 8.49%.
Which sector and indices does Emcure Pharmaceuticals belong to?
NSE classifies Emcure Pharmaceuticals under Healthcare; it is a member of Nifty 500.
Follow Emcure Pharmaceuticals with research you can verify. Add it to a watchlist, see screens and charts, and get calls from SEBI-registered research analysts with recorded track records.
Start free trial